Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Cash from Financing Activities: 2019-2025

Historic Cash from Financing Activities for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to $4.8 million.

  • Biodesix's Cash from Financing Activities rose 3248.61% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year decrease of 80.36%. This contributed to the annual value of $52.0 million for FY2024, which is 78.69% up from last year.
  • Biodesix's Cash from Financing Activities amounted to $4.8 million in Q3 2025, which was down 50.74% from $9.8 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Cash from Financing Activities registered a high of $51.3 million during Q2 2024, and its lowest value of -$4.4 million during Q4 2021.
  • Its 3-year average for Cash from Financing Activities is $8.7 million, with a median of $791,000 in 2024.
  • Data for Biodesix's Cash from Financing Activities shows a peak YoY increase of 7,861.51% (in 2022) and a maximum YoY decrease of 671.97% (in 2022) over the last 5 years.
  • Over the past 5 years, Biodesix's Cash from Financing Activities (Quarterly) stood at -$4.4 million in 2021, then skyrocketed by 1,059.16% to $41.8 million in 2022, then tumbled by 48.08% to $21.7 million in 2023, then slumped by 100.83% to -$181,000 in 2024, then skyrocketed by 3,248.61% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $9.8 million for Q2 2025, and $97,000 during Q1 2025.